An influenza vaccination causes the body to form antibodies that circulate in the blood, but which are directed against constantly changing virus components. This means that the vaccine must be re-administered each...
The Centre for Individualised Infection Medicine (CiiM) is continuing to gain structure and establishment is progressing rapidly. Since summer 2019, this has been accompanied by the new dual leadership of CiiM directors...
For a long time, itaconic acid was only known as a metabolic product of fungi. Its function was unknown, but for decades it has been used industrially for polymer production. In 2013, it was surprisingly discovered as...
Ascenion GmbH, technology transfer partner of the Helmholtz Centre for Infection Research (HZI), announces the take-over of its portfolio company WBC Drug Delivery Technologies (WBC) by Klaria Pharma Holding AB in an...
If you want to protect yourself from the flu, you have to be vaccinated anew every year because the viruses are constantly changing the components to which our immune system responds. Our immune system primarily reacts...
With their project Vaccine for Prevention and Treatment of Trypanosoma cruzi Infection (CRUZIVAX), a consortium of eleven partners coordinated by the Helmholtz Centre for Infection Research has been awarded funding...
In the 1950s, researchers discovered bottromycins – natural substances produced by bacteria with antibiotic activity. Since these substances even kill human pathogens such as the hospital germ MRSA...
As part of the “Big Data in den Lebenswissenschaften der Zukunft” (“Big data in the life sciences of the future”) call, the Lower Saxony Ministry of Science and Culture and the Volkswagen Foundation are supporting 16...
Das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) veranstaltet am 27. und 28. Juni 2019 zum neunten Mal das HIPS-Symposium, bei dem führende Wissenschaftler der internationalen Wirkstoff-Forschung...
